Hepatitis C infection in hemodialysis patients: A review

Digdem Ozer Etik1, Serkan Ocal1, Ahmet Sedat Boyacioglu1

  • 1Digdem Ozer Etik, Serkan Ocal, Ahmet Sedat Boyacioglu, Department of Gastroenterology, Baskent University, 06000 Ankara, Turkey.

Insights

Hepatitis C virus (HCV) infection significantly impacts patients with end-stage renal disease (ESRD). Early diagnosis and treatment of HCV before kidney transplantation (KT) improve survival rates and prevent post-transplant complications.

Area of Science:

  • Nephrology
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV)-related liver disease is a major cause of death in end-stage renal disease (ESRD) patients undergoing dialysis or kidney transplantation (KT).
  • HCV-infected renal transplant recipients have a better survival rate than those on dialysis waiting lists.
  • Early diagnosis and treatment of HCV before KT are crucial for preventing post-transplant complications and reducing mortality.

Purpose of the Study:

  • To review the significance of HCV infection in ESRD patients.
  • To evaluate diagnostic and treatment strategies for HCV in ESRD patients.
  • To discuss the implications of HCV treatment on KT outcomes.

Main Methods:

  • Review of existing literature on HCV in ESRD patients.
  • Discussion of diagnostic methods including anti-HCV antibodies, HCV RNA, and liver biopsy for fibrosis staging.
  • Analysis of treatment options such as interferon monotherapy and combination therapy with ribavirin.

Main Results:

  • Conventional and pegylated interferon monotherapy show similar efficacy and safety in HCV-infected hemodialysis patients, with sustained viral responses (SVRs) around 30-40%.
  • Combination therapy with interferon and ribavirin is supported by limited reports for ESRD patients, requiring careful monitoring.
  • Patients achieving SVR are strong candidates for KT.

Conclusions:

  • Early and effective management of HCV infection in ESRD patients is vital for improving outcomes, particularly for those awaiting or undergoing KT.
  • Liver biopsy is valuable for staging fibrosis and guiding treatment decisions.
  • ESRD patients with advanced liver disease may benefit from combined liver-KT evaluation.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
3.5K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.9K
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
59
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
369
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.6K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
968